Archives: Agenda

Adaptive randomization can help conserve scarce patient data by increasing learning efficiency in early oncology trials. Its value depends on sponsors entering development with clear priorities around one or two target indications. Without that discipline, adaptive designs risk adding operational complexity to broad, unfocused programs without yielding a clean development signal. This presentation will explore adaptive randomization and its utility in:

• Conserving scarce patient data in early development
• Improving signal detection through intentional focus
• Rewarding discipline over broad exploratory ambition

• Aligning clinical trials with today’s investment priorities
• Building investor value: From inflection points to unique positioning
• Strategic connections for oncology clinical trial funding

• Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
• Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
• Best practices for tissue and liquid biopsy selection, handling, and quality assurance, including considerations for ctDNA and MRD testing.
• Case-based examples demonstrating optimal specimens for clinical trial enrollment, as well as common pitfalls in tissue and ctDNA/MRD workflows leading to case failures.
• How Natera harnesses real-world data from its commercial pipeline to accelerate clinical trial advancement and enrollment

• Why most oncology trial delays are designed in before the first patient is enrolled
• How Pharma, Biotech and CRO teams are using AI to eliminate amendments before they happen
• What it takes to build a protocol that actually works operationally, globally, and regulator-ready from day one

• Incorporating patient-centric strategies in trial designs to reduce patient burden
• Overview of new innovations that can be included in studies to increase patient centricity
• Adopting a patient-first mindset when designing trial protocols for patient-friendly studies

• Understanding the unique challenges biotechs face to reduce roadblocks and ensure clinical trial success
• Weighing up in-house capacity versus budget to ensure effective outsourcing decisions
• Working with limited resources to ensure regulatory compliance and minimize roadblocks

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon giftcards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Simplifying trial design and procedures to reduce operational complexity
• Implementing RBQM strategies to identify and mitigate roadblocks to reduce delays